In yesterday’s Wall Street session, Bristol-Myers Squibb Co. (NYSE:BMY) shares traded at $51.92, down -1.89% from the previous session.
BMY stock price is now 2.32% away from the 50-day moving average and 8.49% away from the 200-day moving average. The market capitalization of the company currently stands at $105.26B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $75 to $55, Citigroup Downgraded its rating from Buy to Neutral for Bristol-Myers Squibb Co. (NYSE: BMY). On October 17, 2024, Bernstein recently initiated its ‘Mkt Perform’ rating on the stock quoting a target price of $56, while ‘Barclays’ rates the stock as ‘Equal Weight’
In other news, BOERNER CHRISTOPHER S., Chief Executive Officer bought 2,000 shares of the company’s stock on Dec 05 ’23. The stock was bought for $99,560 at an average price of $49.78. Upon completion of the transaction, the Chief Executive Officer now directly owns 82,672 shares in the company, valued at $4.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 28 ’23, Chief Executive Officer BOERNER CHRISTOPHER S. bought 3,071 shares of the business’s stock. A total of $150,049 was incurred on buying the stock at an average price of $48.86. This leaves the insider owning 79,384 shares of the company worth $4.12 million. A total of 0.08% of the company’s stock is owned by insiders.
During the past 12 months, Bristol-Myers Squibb Co. has had a low of $39.35 and a high of $56.77. As of last week, the company has a debt-to-equity ratio of 3.17, a current ratio of 1.16, and a quick ratio of 1.02. The fifty day moving average price for BMY is $50.7412 and a two-hundred day moving average price translates $47.8587 for the stock.
The latest earnings results from Bristol-Myers Squibb Co. (NYSE: BMY) was released for 2024-06-30. The net profit margin was -14.06% and return on equity was -26.70% for BMY. The company reported revenue of $12.2 billion for the quarter, compared to $11.23 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.69 percent. For the current quarter, analysts expect BMY to generate $11.28B in revenue.
